Proper diagnosis of invasive aspergillosis is challenging as conventional methods lack sensitivity and are complicated due to time-consuming incubation processes. In order to meet the requirement for early diagnosis the new Aspergillus specific point-of-care test LFA-IMMYTM was evaluated with respect to the ability to accurately detect Aspergillus in broncho-alveolar fluids and sputa and to clarify the potential of cross reactivity with other fungal pathogens.
Respiratory specimens and the diagnostic accuracy of aspergillus lateral flow assays (LFA-IMMYTM): real life data from a multicenter study / Lass-Flörl, Cornelia; Lo Cascio, Giuliana; Nucci, Marcio; Camargo Dos Santos, Marielle; Colombo, Arnaldo Lopes; Vossen, Matthias; Willinger, Birgit. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 25:12(2019), pp. 1563.e1-1563.e3. [10.1016/j.cmi.2019.08.009]
Respiratory specimens and the diagnostic accuracy of aspergillus lateral flow assays (LFA-IMMYTM): real life data from a multicenter study
Lo Cascio, Giuliana;
2019-01-01
Abstract
Proper diagnosis of invasive aspergillosis is challenging as conventional methods lack sensitivity and are complicated due to time-consuming incubation processes. In order to meet the requirement for early diagnosis the new Aspergillus specific point-of-care test LFA-IMMYTM was evaluated with respect to the ability to accurately detect Aspergillus in broncho-alveolar fluids and sputa and to clarify the potential of cross reactivity with other fungal pathogens.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
